Table 2. Comparison of different quantitative parameters between malignant and benign breast lesions for T-SWE.

Variables		Overall (n = 225)		P*	≤10 mm (n = 67)		P*	10–20 mm (n = 108)		P*	>20 mm (n = 50)		P*
		Benign (n = 178)	Malignant (n = 47)		Benign (n = 60)	Malignant (n = 7)		Benign (n = 92)	Malignant (n = 16)		Benign (n = 26)	Malignant (n = 24)
Emean	kPa	15.90 ± 10.07(5.70–89.40)	64.66 ± 28.01(8.60–130.80)	<0.001	13.31 ± 5.99(5.70–46.10)	47.13 ± 30.07(12.90–101.80)	<0.001	16.63 ± 10.83(6.10–89.40)	65.53 ± 26.30(8.60–96.80)	<0.001	19.28 ± 13.23(6.40–59.30)	69.19 ± 27.69(19.40–130.80)	<0.001
	m/s	2.19 ± 0.59(1.39–5.82)	4.48 ± 1.32(1.70–7.65)	<0.001	2.04 ± 0.39(1.39–3.70)	3.85 ± 1.55(2.08–6.70)	<0.001	2.24 ± 0.64(1.40–5.82)	4.44 ± 1.20(1.70–5.98)	<0.001	2.36 ± 0.74(1.42–4.24)	4.68 ± 1.32(2.01–7.65)	<0.001
ESD	kPa	5.72 ± 5.02(0.60–35.10)	39.91 ± 13.84(1.10–54.80)	<0.001	4.34 ± 4.49(0.60–28.10)	25.09 ± 19.35(1.10–54.80)	<0.001	5.82 ± 4.05(0.60–30.10)	38.39 ± 12.51(1.20–53.20)	<0.001	8.58 ± 7.61(1.90–35.10)	45.25 ± 9.22(18.60–54.00)	<0.001
	m/s	0.39 ± 0.24(0.03–1.49)	1.80 ± 0.64(0.09–2.77)	<0.001	0.30 ± 0.22(0.03–1.19)	1.07 ± 0.75(0.09–1.92)	<0.001	0.41 ± 0.21(0.06–1.20)	1.70 ± 0.56(0.12–2.48)	<0.001	0.49 ± 0.33(0.21–1.49)	2.08 ± 0.47(1.10–2.77)	<0.001
Eratio	kPa	2.28 ± 1.76(0.52–14.29)	7.44 ± 5.01(1.01–21.30)	<0.001	1.78 ± 0.73(0.62–4.08)	6.42 ± 6.35(1.01–19.30)	<0.001	2.36 ± 2.02(0.82–14.29)	8.10 ± 5.28(1.39–21.30)	<0.001	3.15 ± 2.12(0.52–8.34)	7.30 ± 4.56(1.47–17.45)	<0.001
	m/s	1.39 ± 0.43(0.46–3.70)	2.52 ± 0.93(1.00–4.56)	<0.001	1.27 ± 0.28(0.46–1.92)	2.23 ± 1.15(1.00–4.27)	<0.001	1.42 ± 0.46(0.86–3.70)	2.62 ± 0.91(1.17–4.56)	<0.001	1.57 ± 0.54(0.72–2.70)	2.55 ± 0.89(1.04–4.15)	<0.001

Emean = the mean elasticity; E_SD = standard deviation of the elasticity; Eratio = the ratio elasticity.

^*Comparisons between benign and malignant lesions.